Medifast Inc MED

NYS: MED | ISIN: US58470H1014   24/04/2024
33,57 USD (+0,45%)
(+0,45%)   24/04/2024

5 oktober 2023 · Medifast Named as One of the "Best Companies To Work For" by U.S. News & World Report · Persbericht

13 september 2023 · OPTAVIA ACTIVE™ Now Available · Persbericht

7 september 2023 · Medifast Announces Quarterly Dividend · Persbericht

7 september 2023 · Medifast Survey Finds 8 out of 10 U.S. Adults say Practicing Daily "Self-Care Habits" is a Priority · Persbericht

7 augustus 2023 · Medifast Announces Second Quarter 2023 Financial Results · Persbericht

27 juli 2023 · Medifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE™ · Persbericht

24 juli 2023 · Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2023 · Persbericht

15 juni 2023 · Medifast Announces Quarterly Dividend · Persbericht

1 mei 2023 · Medifast Announces First Quarter 2023 Financial Results · Persbericht

17 april 2023 · Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023 · Persbericht

3 april 2023 · Medifast Named to Financial Times' List of The Americas' Fastest Growing Companies · Persbericht

16 maart 2023 · Medifast Announces Quarterly Dividend · Persbericht

2 maart 2023 · Medifast Appoints Steven Zenker as Vice President of Investor Relations · Persbericht

21 februari 2023 · Medifast Announces Fourth Quarter and Full Year 2022 Financial Results · Persbericht

7 februari 2023 · Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022 · Persbericht

8 december 2022 · Medifast Announces Quarterly Dividend · Persbericht

5 december 2022 · Medifast Survey Indicates Consumer Focus on Health and Wellbeing Remains Strong · Persbericht

16 november 2022 · Medifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies List · Persbericht

3 november 2022 · Medifast Announces Third Quarter 2022 Financial Results · Persbericht

2 november 2022 · Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021* · Persbericht

Mijn selecties